NEW YORK – Pacific Biosciences reported after the close of the market Thursday that its fourth quarter 2019 revenues rose 43 percent.
The long-read sequencing technologies firm reported Q4 total revenues of $27.9 million, up from $19.5 million in Q4 of 2018 and beating analysts' average estimate of $25.5 million.